Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
15:45
/
50%
€157.30
Target price
25.04.27
€203.01
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.04.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | - |
| iShares Core DAX® | -1,74 % |
| iShares Nasdaq 100 | 2,81 % |
| iShares Nikkei 225® | -0,11 % |
| iShares S&P 500 | 0,97 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its price target raised by The Goldman Sachs Group, Inc. from $231.00 to $238.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat